| For Immediate Release | Contact: Gary K. Bennett |
| May 31, 2001 | (860-648-8004) |
|
Fourth Quarter |
Fiscal Year |
||||||
|
2001 |
2000 |
2001 |
2000 |
||||
|
Sales |
$137,471,000 |
$162,854,000 |
$ 552,960,000 |
$610,726,000 |
|||
|
========== |
========== |
========== |
========== |
||||
|
Earnings (loss) before charges |
$ (1,350,000) |
$ 8,618,000 |
$ (1,121,000) |
$ 45,175,000 |
|||
|
Restructuring and other special charges (1) (2) |
(26,891,000) |
(6,200,000) |
(31,310,000) |
(6,200,000) |
|||
|
|
|
|
|
||||
|
Earnings (loss) before income taxes |
$(28,241,000) |
$ 2,418,000 |
$ (32,431,000) |
$ 38,975,000 |
|||
|
|
|
|
|
||||
|
Taxes on earnings before charges (3) |
$ (500,000) |
$ 2,800,000 |
$ 1,400,000 |
$ 15,200,000 |
|||
|
Tax benefit of charges |
(8,600,000) |
(2,100,000) |
(10,200,000) |
(2,100,000) |
|||
|
|
|
|
|
||||
|
Provision (benefit) for income taxes |
$ (9,100,000) |
$ 700,000 |
$ (8,800,000) |
$ 13,100,000 |
|||
|
|
|
|
|
||||
|
Net earnings (loss) before charges |
$ (850,000) |
$ 5,818,000 |
$ (2,521,000) |
$29,975,000 |
|||
|
Restructuring and other special charges, net of taxes (1)(2) |
|
|
|
|
|||
|
|
|
|
|
||||
|
Net earnings (loss) |
$(19,141,000) |
$ 1,718,000 |
$(23,631,000) |
$25,875,000 |
|||
|
========== |
========== |
========== |
========== |
||||
|
Per share of common stock: |
|||||||
|
Basic (4) |
|||||||
|
Before charges |
$ (.04) |
$ .26 |
$ (.11) |
$ 1.35 |
|||
|
Restructuring and other special charges |
(.83) |
(.18) |
(.96) |
(.18) |
|||
|
|
|
|
|
||||
|
$ (.87) |
$ .08 |
$ (1.07) |
$ 1.17 |
||||
|
========== |
========== |
========== |
========== |
||||
|
Diluted (4) |
|||||||
|
Before charges |
$ (.04) |
$ .26 |
$ (.11) |
$ 1.34 |
|||
|
Restructuring and other special charges |
(.83) |
(.18) |
(.96) |
(.18) |
|||
|
|
|
|
|
||||
|
$ (.87) |
$ .08 |
$ (1.07) |
$ 1.16 |
||||
|
========== |
========== |
========== |
========== |
||||
|
Average shares outstanding: |
|||||||
|
Basic |
22,038,000 |
22,059,000 |
22,017,000 |
22,140,000 |
|||
|
========== |
========== |
========== |
========== |
||||
|
Diluted |
22,038,000 |
22,209,000 |
22,017,000 |
22,390,000 |
|||
|
========== |
========== |
========== |
========== |
||||
See notes on next page.
(1)
Included in the fiscal year ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges, recorded in the first and fourth quarters of the fiscal year, amounted to $31,310,000 before income taxes and $21,110,000 after taxes ($.96 per diluted share). Included in the first quarter ended July 31, 2000 were restructuring charges that amounted to $4,419,000 before income taxes and $2,819,000 after taxes ($.13 per diluted share) and in the fourth quarter ended April 30, 2001 restructuring and other special charges that amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).(2)
Included in the three and twelve months ended April 30, 2000 was a charge recorded for excess costs caused by cost overruns and inefficiencies realized in the initial production runs of products introduced in that year. This charge was included in the cost of product sales and amounted to $6,200,000 before income taxes and $4,100,000 after taxes ($.18 per diluted share).(3)
The income tax expense associated with the loss before charges in the fiscal year ended April 30, 2001 arose principally from the non-deductibility of goodwill amortization.(4)
Earnings per share information was computed separately for each period. Therefore, the sum of such quarterly share amounts may differ from the total for the year.
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
|
Three Months Ended |
|||
|
In thousands (except per share amounts) |
2001 |
2000 |
|
|
Revenue: |
|||
|
Product sales |
$125,914 |
$149,534 |
|
|
Service |
11,557 |
13,320 |
|
|
|
|
||
|
137,471 |
162,854 |
||
|
|
|
||
|
Costs and Expenses: |
|||
|
Cost of product sales |
93,075 |
100,194 |
|
|
Cost of service |
9,426 |
7,146 |
|
|
Selling, general and administrative |
37,693 |
39,633 |
|
|
Research and development expenses |
6,746 |
8,138 |
|
|
Goodwill amortization |
2,230 |
2,286 |
|
|
Restructuring charge |
13,120 |
--- |
|
|
|
|
||
|
162,290 |
157,397 |
||
|
|
|
||
|
Operating income (loss) |
(24,819) |
5,457 |
|
|
Other income (expense) |
(201) |
(26) |
|
|
Interest expense |
(3,221) |
(3,013) |
|
|
|
|
||
|
Earnings (loss) before income taxes(1) |
(28,241) |
2,418 |
|
|
Provision (benefit) for income taxes |
(9,100) |
700 |
|
|
|
|
||
|
Net earnings (loss) (1) |
$(19,141) |
$ 1,718 |
|
|
======= |
======= |
||
|
Per share of common stock: (1) |
|||
|
Basic |
$ (.87) |
$ .08 |
|
|
Diluted |
$ (.87) |
$ .08 |
|
|
Dividends |
$ .08 |
$ .08 |
|
|
Average shares outstanding: |
|||
|
Basic |
22,038 |
22,059 |
|
|
Diluted |
22,038 |
22,209 |
|
(1)
Included in the fourth quarter ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
|
Fiscal Year Ended |
|||
|
In thousands (except per share amounts) |
2001 |
2000 |
|
|
Revenue: |
|||
|
Product sales |
$504,391 |
$556,985 |
|
|
Service |
48,569 |
53,741 |
|
|
|
|
||
|
552,960 |
610,726 |
||
|
|
|
||
|
Costs and Expenses: |
|||
|
Cost of product sales |
336,406 |
340,143 |
|
|
Cost of service |
33,761 |
28,719 |
|
|
Selling, general and administrative |
146,399 |
151,701 |
|
|
Research and development expenses |
29,272 |
33,022 |
|
|
Goodwill amortization |
8,943 |
8,639 |
|
|
Restructuring charges |
17,539 |
--- |
|
|
|
|
||
|
572,320 |
562,224 |
||
|
|
|
||
|
Operating income (loss) |
(19,360) |
48,502 |
|
|
Other income |
194 |
1,090 |
|
|
Interest expense |
(13,265) |
(10,617) |
|
|
|
|
||
|
Earnings (loss) before income taxes(1) |
(32,431) |
38,975 |
|
|
Provision (benefit) for income taxes |
(8,800) |
13,100 |
|
|
|
|
||
|
Net earnings (loss) (1) |
$ (23,631) |
$ 25,875 |
|
|
======= |
======= |
||
|
Per share of common stock: (1) |
|||
|
Basic |
$ (1.07) |
$ 1.17 |
|
|
Diluted |
$ (1.07) |
$ 1.16 |
|
|
Dividends |
$ .32 |
$ .32 |
|
|
Average shares outstanding: |
|||
|
Basic |
22,017 |
22,140 |
|
|
Diluted |
22,017 |
22,390 |
|
(1)
Included in the fiscal year ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges, recorded in the first and fourth quarters of the fiscal year, amounted to $31,310,000 before income taxes and $21,110,000 after taxes ($.96 per share on a diluted basis.) Included in the first quarter ended July 31, 2001 were restructuring charges that amounted to $4,419,000 before income taxes and $2,819,000 after taxes ($.13 per diluted share) and in the fourth quarter ended April 30, 2001 restructuring and other special charges that amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
|
|
April 30, 2001 |
April 30, 2000 |
|
|
Assets: |
|||
|
Current Assets: |
|||
|
Cash and short-term cash investments |
$20,866 |
$ 22,954 |
|
|
Accounts receivable |
98,159 |
121,494 |
|
|
Inventories |
69,441 |
86,472 |
|
|
Prepaid expenses |
18,965 |
21,042 |
|
|
Net assets held for sale |
21,369 |
--- |
|
|
|
|
||
|
228,800 |
251,962 |
||
|
|
|
||
|
Property, Plant and Equipment: |
112,572 |
165,341 |
|
|
Less accumulated depreciation |
53,022 |
66,121 |
|
|
|
|
||
|
59,550 |
99,220 |
||
|
|
|
||
|
Intangible Assets: |
243,669 |
245,797 |
|
|
Less accumulated amortization |
36,112 |
27,419 |
|
|
|
|
||
|
207,557 |
218,378 |
||
|
|
|
||
|
Deferred Income Taxes: |
793 |
--- |
|
|
Other Assets: |
4,493 |
3,276 |
|
|
|
|
||
|
$501,193 |
$572,836 |
||
|
======= |
======= |
||
|
Liabilities and Shareholders' Equity: |
|||
|
Current Liabilities: |
|||
|
Notes payable |
$ --- |
$ --- |
|
|
Accounts payable |
48,520 |
58,043 |
|
|
Accrued compensation and benefits |
18,576 |
16,646 |
|
|
Other accrued liabilities |
25,749 |
26,689 |
|
|
Deferred revenue |
13,129 |
8,436 |
|
|
Advances on sales contracts |
1,562 |
2,610 |
|
|
|
|
||
|
107,536 |
112,424 |
||
|
|
|
||
|
Noncurrent Liabilities: |
|||
|
Deferred income taxes |
--- |
8,608 |
|
|
Long-term debt |
169,914 |
194,892 |
|
|
|
|
||
|
169,914 |
203,500 |
||
|
|
|
|
Contingencies and Commitments: |
|||
|
Shareholders' Equity: |
|||
|
Preferred stock, no par value; authorized 10,000,000 shares; no shares issued |
|
|
|
|
Common stock, $1.00 par value; authorized 65,000,000 shares; issued 22,828,742 and 22,779,651 shares |
|
|
|
|
Paid-in capital |
43,835 |
43,615 |
|
|
Retained earnings |
180,082 |
210,749 |
|
|
Treasury stock, at cost (784,837 and 797,444 shares, respectively) |
(16,138) |
(16,397) |
|
|
Unamortized value of restricted stock grants |
(439) |
(557) |
|
|
Accumulated other comprehensive income (loss) |
(6,426) |
(3,278) |
|
|
|
|
||
|
223,743 |
256,912 |
||
|
|
|
||
|
$501,193 |
$572,836 |
||
|
======= |
======= |
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
Fiscal Year Ended |
|||
|
In thousands |
2001 |
2000 |
|
|
Cash Provided by (Used for): |
|||
|
Operating Activities: |
|||
|
Net earnings (loss) |
$(23,631) |
$25,875 |
|
|
Adjustments to reconcile net earnings (loss) |
|||
|
Depreciation and amortization |
27,228 |
25,622 |
|
|
Special charges |
31,310 |
--- |
|
|
Deferred income taxes |
(9,401) |
(1,613) |
|
|
Other non-cash items |
533 |
460 |
|
|
Changes in operating accounts, net of |
|||
|
Receivables |
22,319 |
(13,980) |
|
|
Inventories |
6,205 |
(8,463) |
|
|
Prepaid expenses |
1,963 |
6,044 |
|
|
Accounts payable and accrued expenses |
(19,796) |
(6,855) |
|
|
|
|
||
|
Provided by Operating Activities |
36,730 |
27,090 |
|
|
|
|
||
|
Investing Activities: |
|||
|
Additions to property, plant and equipment |
(14,757) |
(22,313) |
|
|
Proceeds from sale of assets |
13,721 |
--- |
|
|
Business acquisitions |
--- |
(14,744) |
|
|
Intangible and other assets |
(1,982) |
(189) |
|
|
Other, net |
(3,148) |
(4,491) |
|
|
|
|
||
|
(Used for) Investing Activities |
(6,166) |
(41,737) |
|
|
|
|
||
|
Financing Activities: |
|||
|
Purchase of common stock |
--- |
(4,701) |
|
|
Additions of long-term debt |
47,000 |
74,566 |
|
|
Repayments of long-term debt |
(71,978) |
(53,205) |
|
|
Net short-term financing |
--- |
(1,798) |
|
|
Debt issue costs |
(751) |
--- |
|
|
Proceeds from issuance of stock |
113 |
3,305 |
|
|
Dividends on common stock |
(7,036) |
(7,089) |
|
|
|
|
||
|
Provided by (Used for) Financing Activities |
(32,652) |
11,078 |
|
|
|
|
||
|
(Decrease) in Cash and Short-Term Cash Investments |
(2,088) |
(3,569) |
|
|
Cash and Short-Term Cash Investments, Beginning of Year |
22,954 |
26,523 |
|
|
|
|
||
|
Cash and Short-Term Cash Investments, End of Year |
$20,866 |
$22,954 |
|
|
====== |
====== |
||